These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26625131)

  • 21. Longitudinal cytological follow-up of patients with a papanicolaou test interpretation of "atypical squamous cells of undetermined significance" that was followed by a negative reflex test for high-risk human papillomavirus types.
    Rodriguez R; Fadare O
    Int J Gynecol Pathol; 2008 Jan; 27(1):108-12. PubMed ID: 18156984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pap test results among low-income youth: prevalence of dysplasia and practice implications.
    Halcón LL; Lifson AR; Shew M; Joseph M; Hannan PJ; Hayman CR
    J Obstet Gynecol Neonatal Nurs; 2002; 31(3):294-304. PubMed ID: 12033542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
    Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
    Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
    Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital.
    Yarandi F; Shojaei H; Eftekhar Z; Izadi-Mood N
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):207-10. PubMed ID: 19432613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Pap Test terminology and age in the detection of carcinoma invasive and carcinoma in situ in medically underserved California women.
    Howell LP; Tabnak F; Tudury AJ; Stoodt G
    Diagn Cytopathol; 2004 Apr; 30(4):227-34. PubMed ID: 15048955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
    Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Papanicolaou smear abnormalities in inner city Bronx adolescents: prevalence, progression, and immune modifiers.
    Edelman M; Fox AS; Alderman EM; Neal W; Shapiro A; Silver EJ; Spigland I; Suhrland M
    Cancer; 1999 Aug; 87(4):184-9. PubMed ID: 10455205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women.
    Eltoum IA; Chhieng DC; Roberson J; McMillon D; Partridge EE
    Cancer; 2005 Aug; 105(4):194-8. PubMed ID: 15900575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.
    Cox JT
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S15-25. PubMed ID: 16729900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL; Dye T; Grace C; Hiraoka M
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
    Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
    J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
    Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
    Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
    N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.